COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,526 Articles (22,380 medRxiv, 8,146 bioRxiv)

Most recent first Previous |  Page 754: Articles 7531-7540  | Next

Anti-inflammatory therapy with nebulised dornase alfa in patients with severe COVID-19 pneumonia
Porter, J., Inshaw, J., Solis, V. J., Denneny, E., Evans, R., Temkin, M. I., De Vasconcelos, N., Aramburu, I. V., Hoving, D., Basire, D., Crissell, T., Guinto, J., Webb, A., Esmail, H., Johnston, V., Last, A., Rampling, T., Williams, B., Flynn, A., Lukey, P., Birault, V., Papayannopoulos, V.
10.1101/2022.04.14.22272888 — Posted: 2022-04-14
Understanding community level influences on COVID-19 prevalence in England: New insights from comparison over time and space
Joshi, C., Ali, A., O'Connor, T., Chen, L., Jahanshahi, K.
10.1101/2022.04.14.22273759 — Posted: 2022-04-14
The Omicron (B.1.1.529) SARS-CoV-2 variant of concern also affects companion animals
Sanchez-Morales, L., Sanchez-Vizcaino, J. M., Perez-Sancho, M., Dominguez, L., Barroso-Arevalo, S.
10.1101/2022.04.13.488132 — Posted: 2022-04-13
Markers of Fungal Translocation Are Elevated During Post-Acute Sequelae of SARS-CoV-2 Infection and Induce NF-κB Triggered Inflammation.
Giron, L. B., Peluso, M., Ding, J., Kenny, G., Zilberstein, N. F., Koshy, J., Hong, K. Y., Rasmussen, H., Miller, G., Bishehsari, F., Balk, R. A., Moy, J. N., Hoh, R., Lu, S., Goldman, A. R., Tang, H.-Y., Yee, B. C., Chenna, A., Winslow, J. W., Petropoulos, C. J., Kelly, J. D., Wasse, H., Martin, J. N., Liu, Q., Keshavarzian, A., Landay, A., Deeks, S. G., Henrich, T. J., Abdel-Mohsen, M.
10.1101/2022.04.12.488051 — Posted: 2022-04-13
Structural and biochemical mechanism for increased infectivity and immune evasion of Omicron BA.1 and BA.2 variants and their mouse origins
Xu, Y., Wu, C., Cao, X., Gu, C., Liu, H., Jiang, M., Wang, X., Yuan, Q., Wu, K., Liu, J., He, X., Wang, D., Wang, X., Deng, S.-J., Xu, H. E., Yin, W.
10.1101/2022.04.12.488075 — Posted: 2022-04-13
SARS-CoV-2 Delta breakthrough infections in vaccinated patients
Zou, J., Xie, X., Liu, M., Shi, P.-Y., Ren, P.
10.1101/2022.04.12.488092 — Posted: 2022-04-13
Broadly neutralizing and protective nanobodies against diverse sarbecoviruses
Li, M., Ren, Y., Aw, Z. Q., Chen, B., Yang, Z., Lei, Y., Cheng, L., Liang, Q., Hong, J., Yang, Y., Chen, J., Wong, Y. H., Shan, S., Zhang, S., Ge, J., Wang, R., Shi, X., Zhang, Q., Zhang, Z., Chu, J. J. H., Wang, X., Zhang, L.
10.1101/2022.04.12.488087 — Posted: 2022-04-13
Effectiveness of COVID-19 vaccines against hospitalization and death in Canada: A multiprovincial test-negative design study
Nasreen, S., Febriani, Y., Garcia, H. A. V., Zhang, G., Tadrous, M., Buchan, S. A., Righolt, C., Mahmud, S. M., Janjua, N. Z., Krajden, M., Serres, G. D., Kwong, J. Z.
10.1101/2022.04.13.22273825 — Posted: 2022-04-13
Multiplex RT-qPCR assay (N200) to detect and estimate prevalence of multiple SARS-CoV-2 Variants of Concern in wastewater
Fuzzen, M. L. M., Harper, N. B., Dhiyebi, H. A., Srikanthan, N., Hayat, S., Peterson, S. W., Yang, I., Sun, J. X., Edwards, E. A., Giesy, J. P., Mangat, C. S., Graber, T. E., Delatolla, R. E., Servos, M. R.
10.1101/2022.04.12.22273761 — Posted: 2022-04-13
Nowcasting and Forecasting COVID-19 Waves: The Recursive and Stochastic Nature of Transmission
Albani, V. V. L., Albani, R. A. S., Massad, E., Zubelli, J. P.
10.1101/2022.04.12.22273804 — Posted: 2022-04-13

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).